Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for
Kevzara Enrollment Form. Dob (mm/dd/yyyy)* phone* zip code* insurance informationprimary rx insurance namerx insurance phone ( ) policy id # rx bin # patient has no insurance. Web patient enrolment form for more information please contact:
Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for
Web patient consent and enrollment form instructions to ensure your information is processed without delay: Register today when it’s time for a change, target. Save or instantly send your ready documents. Web review resources and information about kevzara® (sarilumab) and rheumatoid arthritis (ra) treatment, as well as answers to commonly asked questions about kevzara®, including details about side effects and how it is used. Kevzara is used to treat adult patients with: Web prescription & enrollment form: Return all completed sections of this consent form through the patientby mail or by fax assistance program, connect Kevzara (sarilumab) for pmr fax completed form to 888.302.1028. Easily fill out pdf blank, edit, and sign them. Web complete kevzara enrollment form online with us legal forms.
Save or instantly send your ready documents. Kevzara (sarilumab) for pmr fax completed form to 888.302.1028. Dob (mm/dd/yyyy)* phone* zip code* insurance informationprimary rx insurance namerx insurance phone ( ) policy id # rx bin # patient has no insurance. Web now approved to treat adult patients with polymyalgia rheumatica (pmr) who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper. Web review resources and information about kevzara® (sarilumab) and rheumatoid arthritis (ra) treatment, as well as answers to commonly asked questions about kevzara®, including details about side effects and how it is used. For questions regarding the patient assistance program, please call. If you are applying forfinancial assistance 4. All information will bekept confidential and will not be released to unauthorized parties without your consent. Completesection 1 sign section 23. Patient’s irst name last name middle initial date of birth Return all completed sections of this consent form through the patientby mail or by fax assistance program, connect